Navigation Links
Week in Review in the Health Outcomes and Pharma Pricing Field from HealthEconomics.Com
Date:2/15/2013

Ponte Vedra Beach, Florida (PRWEB) February 15, 2013

The top news story available on HealthEconomics.Com explored results of a study by the European Consortium in Healthcare Outcomes (ECHOUTCOME) claiming that the QALY (quality-adjusted life years) has failed as a common metric for assessing cost-benefit of drug therapies. The findings have set off a controversial debate on the continued use of the QALY as a measure for deciding whether or not a drug will be reimbursed by payers or health systems. The QALY is used by NICE (the National Institute for Health and Clinical Excellence) for coverage decisions by the National Health Service in the United Kingdom, as well as by Canada and Australia. Generally if a treatment costs more than £20,000-30,000 per QALY, it would not be recommended as cost-effective by NICE.

The study findings caused a backlash of protests by UK-based experts, defending the current system and NICE called the study "limited". More details on the QALY debate can be found on HealthEconomics.Com News.

Another popular news story related to the Pharmacy Benefit Management (PBM) sector. Costco, the largest warehouse club chain in the United States, has entered into the PBM marketplace with the intent to offer services to small and medium-sized companies located near their warehouse stores. Currently, Express Scripts Holding and CVS Caremark dominate the PBM business. PBMs play a significant role in drug coverage decisions and can dramatically impact the success or failure of a pharmaceutical drug product’s success in the marketplace. For more on the impact of Costco on the PBM marketplace, visit the

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Up to the Challenge: Careers in Science in the Midst of Drastic Change, According to Wysebridge Patent Bar Review
2. Sigma-Aldrich Corporation Will Hold Its Annual Business Review March 21, 2013
3. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
4. Wysebridge Patent Bar Review Discusses Major Changes To The Patent Bar Exam
5. New EMR Comparison Website Launches Crowdsourcing Electronic Medical Record Software Reviews and Comparisons
6. Independent Marketing Automation Software Expert gives Positive review on MindMatrix's platform, AMP
7. Global Metabolomics Market Reviewed & Forecast in New In-Demand Report Available at MarketPublishers.com
8. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
9. Wysebridge Patent Bar Review Announces the Launch of News Blog
10. Review Module Headlines BSI 8.6 Release for Enterprise Biobank Software
11. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Campbell, California (PRWEB) March 31, 2015 ... management consulting firm with operations in California, Oregon, ... formal launch of its Merger and Acquisition (M&A) ... , Peter Adams, VP Client Services and M&A ... repeatedly shown that the vast majority of M&A ...
(Date:3/30/2015)... Calif. , March 30, 2015  NuGene ... its subsidiary corporation, NuGene BioPharma, Inc. has added ... Dr. Guan is an internationally recognized ... finishing his college education at Peking University, ... Ph.D. degree from the University of North Carolina, ...
(Date:3/30/2015)...    Intrexon Corporation (NYSE: XON ... Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, ... exclusive strategic collaboration and license agreement to develop ... therapies. This collaboration advances Merck Serono,s comprehensive, science-driven ... immune system,s natural ability to fight tumors. ...
(Date:3/30/2015)... , March 30, 2015 ... auf    Richmond Pharmacology ist das erste ... Amyloidose-Zentrum am Royal Free Hospital in ... zur Untersuchung eines RNAi-Therapeutikums Studienversuche an einem Patienten ... von Transthyretin vermittelter Amyloidose entwickelt (ATTR), einer seltenen ...
Breaking Biology Technology:Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... Cara Therapeutics, Inc.,announced today that it ... funding,to its original $24 million Series C ... was led by new investor, Devon Park ... investors participating,in the round included; Ascent Biomedical ...
... SILVER SPRING, Md., July 24 United,Therapeutics Corporation ... will,release its 2008 second quarter financial results before ... United Therapeutics will host a half-hour teleconference ... Time. The teleconference is accessible,by dialing 1-800-603-1777, with ...
... Agrees to Increase Original Warrant Amount by an Additional ... ... MTA: CTIC) today announced that a single institutional investor,has agreed to purchase, ... conversion price of $0.79 per share, and a,warrant to purchase approximately 28.2 ...
Cached Biology Technology:Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 3
(Date:3/12/2015)... , March 12, 2015 ... standardized identity and access management (IAM) solution for ... schedule. With Beta System,s new IAM package, customers ... practices gleaned from multiple IAM implementations across different ... software as well as any necessary services and ...
(Date:3/10/2015)... BOULDER, Colo. , March 10, 2015 ... Space Flight "Personalized Medicine in Human ... Ph.D. and Thomas J. Goodwin , Ph.D. was ... articles of the past two years. Specifically, ... three most downloaded scientific papers published in 2013 and ...
(Date:3/3/2015)... March 3, 2015 Cryoport, Inc. ... advanced cryogenic logistics solutions for the life ... cells, cell lines, clinical research organizations, vaccine ... announced the expansion of its relationship with ... ("Fred Hutch") Clinical Research Division with the ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... Louis, MO Current research provides a novel model for ... al, "Characterization of the KRN cell transfer model of rheumatoid ... mouse," appears in the September 2010 issue of The ... population is affected by rheumatoid arthritis, and women are affected ...
... University in Washington, D.C., have received a five-year, $3.15 million ... new interdisciplinary program in the environmental affects and policy implications ... ... the Integrative Graduate Education and Research Traineeship (IGERT), which enables ...
... to the slate of expertswhich includes military medical ... Partnerships, on September 23, 2010, at the Omni ... a premier opportunity for representatives of the public ... medical partnerships to benefit our nation,s wounded warriors ...
Cached Biology News:Casing the joint 2Carnegie Mellon receives funding to create new program studying environmental impact of nanotechnology 2Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium 2Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium 3
Homo sapiens palladin...
Request Info...
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: